TTRX
Turn Therapeutics Inc. Common Stock
NASDAQ: TTRX · HEALTHCARE · BIOTECHNOLOGY
$3.69
+3.81% today
Updated 2026-04-30
Market cap
$107.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$3 – $10
Volume
0.0M
Turn Therapeutics Inc. Common Stock (TTRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | $-1.38M | $-1.36M | $-2.56M |
| Capital expenditures | $44306.00 | $99475.00 | $152986.00 |
| Depreciation | $43920.00 | $47483.00 | — |
| Stock-based comp | $640264.00 | $352833.00 | $419245.00 |
| Free cash flow | $-1.42M | $-1.46M | $-2.72M |
| Investing cash flow | $-44306.00 | $-99475.00 | — |
| Financing cash flow | $500000.00 | $1.15M | — |
| Dividends paid | — | — | — |
| Share repurchases | — | — | — |
| Debt repayment | — | — | — |
| Net change in cash | — | — | — |